ICER’s newly-named president elect on drug pricing and ICER’s future
- blonca9
- Jun 29, 2023
- 1 min read
Sarah Emond was named president-elect of ICER. She explains her view of ICER’s role and where she sees drug pricing headed in the future.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.
bottom of page